Britannia Life Sciences Inc (BLAB)

Britannia Life Sciences Inc. recorded a single insider purchase on March 11, 2026. Director Peter James Shippen acquired 20,000 shares for a total value of 1,900.00. This transaction represents the most recent activity involving company leadership, occurring over three months ago.
Ticker: BLAB Exchange: CNX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
Shippen, Peter James 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
296.48
Quantity 48,166 +11.0%
Value CA$2,179,757
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-11 2026-03-11 B Purchase

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
48,166 +11.0%
296.48
CA$2,179,757
48,166 +11.0% 296.48 CA$2,179,757